GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹243 Cr | ₹269 Cr | ₹320 Cr | ₹3.82 Cr | ₹3.93 Cr |
What is the latest Total Debt ratio of GLAND PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹243 Cr |
| Mar2025 | ₹269 Cr |
| Mar2024 | ₹320 Cr |
| Mar2023 | ₹3.82 Cr |
| Mar2022 | ₹3.93 Cr |
How is Total Debt of GLAND PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹243 Cr | -9.60 | |
| Mar2025 | ₹269 Cr | -15.81 | |
| Mar2024 | ₹320 Cr | 8,269.07 | |
| Mar2023 | ₹3.82 Cr | -2.85 | |
| Mar2022 | ₹3.93 Cr | - | |
Compare Total Debt of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹50,653.4 Cr | 6.8% | 3.2% | 59.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,483.0 Cr | -3.2% | -7.8% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,248.0 Cr | 1% | 0.9% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,822.0 Cr | -1.8% | -4.8% | 32.2% | Stock Analytics | |
| CIPLA | ₹105,427.0 Cr | -3.1% | -6.5% | -12.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,492.3 Cr | -1.7% | 3.1% | -3.5% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 6.8% |
3.2% |
59.2% |
| SENSEX | -1.2% |
-6.4% |
-10.8% |
You may also like the below Video Courses